高级检索
当前位置: 首页 > 详情页

Identification of Antioxidative Components in ChuanKeZhi Injection and Discussion on Its Quality Control Method

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Guangzhou ImVin Pharmaceut Co Ltd, Res & Dev Ctr New Drugs, Guangzhou, Guangdong, Peoples R China [2]Tongji Univ, Sch Life Sci, Dept Bioinformat, Shanghai, Peoples R China [3]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China
出处:
ISSN:

关键词: Antioxidant flow injection ChuanKeZhi asthma reactive oxygen species quality control

摘要:
Intoduction: ChuanKeZhi, an intramuscular Traditional Chinese Medicine injection, has been used to treat asthma for more than twenty years in China and good clinical results have been received. However, the material basis remains to be elucidated. Materials and Method: Aiming at disclosing the antioxidants in ChuanKeZhi, an online identification system adopting high performance liquid chromatography tandem chemiluminescence detector was carried out. Two lignanosides named (-)-olivil-4'-O-glucopyranoside and (+)-cycloolivil were proved to be mainly responsible for scavenging hydrogen peroxide, and their structures were confirmed by NMR data. Chemiluminescence inhibition was calculated as the ratio of the maximum intensity in the presence of injection to that in its absence, and logarithmic values of inhibition ratio showed a good linear correlation with the concentrations of cycloolivil in the range of 4.950-158.3 mu g/mL (R-2 = 0.9917). Principal component analysis disclosed that contents of these two compounds explained mostly the variance of total antioxidative activities of different batches. Result: This work revealed the components contributed to antioxidative activity of ChuanKeZhi injection and might provide some information for new drug development and better quality control method.

语种:
WOS:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 药学
JCR分区:
出版当年[2015]版:
Q4 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Guangzhou ImVin Pharmaceut Co Ltd, Res & Dev Ctr New Drugs, Guangzhou, Guangdong, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号